Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
A selection study in treatment naive HIV patients to compare the virologic success rate of
once daily antiretroviral treatment regimens at the 48th week with Epzicom(lamivudine and
abacavir) plus efavirenz and Epzicom plus ritonavir boosted atazanavir. The superior regimen
will be hired to the comparative study to the current first line regimen (tenofovir plus
lamivudine plus efavirenz)